Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis

Public health impact of antiviral therapy for hepatitis C in the United States

(2009) Michael L. Volk et al.   HEPATOLOGY

Forewarned is forearmed

(2009) Stefan Zeuzem   JOURNAL OF HEPATOLOGY

HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C

(2009) Stella De Nicola et al.   JOURNAL OF HEPATOLOGY

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

(2009) Pierre-Yves Bochud et al.   JOURNAL OF HEPATOLOGY

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

(2009) T. Reiberger et al.   JOURNAL OF VIRAL HEPATITIS

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection

(2009) T. J. S. Cross et al.   JOURNAL OF VIRAL HEPATITIS

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

(2009) Christophe Hézode et al.   NEW ENGLAND JOURNAL OF MEDICINE

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors

(2008) Sharif B. Missiha et al.   GASTROENTEROLOGY

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

(2008) Robert Flisiak et al.   HEPATOLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India

(2008) Syed S Hissar et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY